IQ EQ FUND MANAGEMENT IRELAND Ltd Cuts Position in HCA Healthcare, Inc. $HCA

IQ EQ FUND MANAGEMENT IRELAND Ltd cut its position in HCA Healthcare, Inc. (NYSE:HCA) by 50.4% in the third quarter, HoldingsChannel reports. The institutional investor owned 2,136 shares of the company’s stock after selling 2,169 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in HCA Healthcare were worth $910,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Clearstead Trust LLC boosted its stake in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares during the period. Harbor Capital Advisors Inc. boosted its position in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at $40,000. Compound Global Advisors LLC acquired a new position in HCA Healthcare during the 3rd quarter worth $44,000. Finally, True Wealth Design LLC boosted its stake in shares of HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after buying an additional 70 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 2.3%

HCA stock opened at $501.89 on Friday. The business has a 50 day simple moving average of $479.97 and a 200-day simple moving average of $442.08. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $527.55. The company has a market capitalization of $114.53 billion, a P/E ratio of 17.68, a PEG ratio of 1.58 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the prior year, the business earned $6.22 EPS. HCA Healthcare’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.15%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on HCA shares. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target for the company. in a research note on Monday, December 15th. Truist Financial increased their target price on HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. KeyCorp set a $503.00 target price on HCA Healthcare in a research note on Wednesday, January 28th. Finally, Cantor Fitzgerald raised their price objective on shares of HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $521.55.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.